TCL Archive Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock December 17, 2013
TCL Archive FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe December 5, 1986
TCL Archive President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget February 5, 1999
TCL Archive In Brief: Cooper Resigns From DPC Board, Bettinghaus Names, Chairman; William Dewyus Leaves NCI September 13, 1985